BWLSA
CTKB icon

Blue Water Life Science Advisors’s Cytek Biosciences CTKB Stock Holding History

Blue Water Life Science Advisors’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,109,000
Closed -$10.2M – 9
2023
Q1 		$10.2M Sell
1,109,000
-191,000
-15% -$2.05M 6.74% 7
2022
Q4 		$13.3M Sell
1,300,000
-800,000
-38% -$10.8M 8.92% 6
2022
Q3 		$30.9M Hold
2,100,000
– – 12.48% 3
2022
Q2 		$22.5M Buy
+2,100,000
New +$20.9M 12.24% 5

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Blue Water Life Science Advisors's CTKB Position: Q2 2023 in Review

Blue Water Life Science Advisors sold out of Cytek Biosciences (CTKB) in Q2 2023, closing a stake of 1,109,000 shares — an estimated $10.2M sold.

Blue Water Life Science Advisors first reported a position in CTKB in Q2 2022 and held it in 4 quarters. The position peaked at $30.9M in Q3 2022. 101 funds tracked by Wall St. Rank hold CTKB as of Q2 2023.

  • Blue Water Life Science Advisors reported no remaining Cytek Biosciences position as of Q2 2023 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 1,109,000 Cytek Biosciences shares in Q2 2023, an estimated $10.2M.
  • Blue Water Life Science Advisors first reported a position in Cytek Biosciences in Q2 2022 and held it in 4 quarters.
  • Blue Water Life Science Advisors's Cytek Biosciences position peaked at $30.9M in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2023.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.